Jung Min Jo is a partner at Bae, Kim & Lee LLC and leads the firm’s healthcare practice. For more than 15 years, Mr Jo has represented a number of domestic and foreign pharmaceutical and medical devices companies. He also works closely with the firm’s fair trade team and data privacy experts in the healthcare practice. Recently, he successfully defended a foreign pharmaceutical company before the Korea Food and Drug Administration on the anti-kickback charges that had been aggressively brought by the agency based on the newly adopted anti-corruption laws as a part of the Korean government’s efforts to tackle industry-wide problems.

He has assisted a number of foreign pharmaceutical and medical equipment manufacturers in adopting internal compliance rules to conform to the new healthcare laws and implementing the personal information protection regulations that have become a ‘hot’ issue since the new data privacy laws came into effect in 2012. He also trained as a corporate and M&A expert, and has advised foreign healthcare companies in their inbound investments into the Korean market, including acquisitions of Korean pharmaceutical and medical device companies.

Mr Jo is currently a member of the Regulation Review Committee under the Ministry of Food and Drug Safety and serves as the auditor of the Korea Institute of Drug Safety and Risk Management. In 2012, he was selected as an External Counsel of the Year by Asian-MENA Counsel, a Hong Kong-based legal publication. Mr Jo received an LLB degree from Seoul National University College of Law in 1994 and an LLM degree from Columbia Law School in 2004.